ACR deal will eliminate global comms difficulties, says GPSI

By Gareth Macdonald

- Last updated on GMT

Related tags: Contract research organization

The new partnership with Indian CRO Abridge Clinical Research (ACR) is a unique collaboration offering cost efficient and timely trial solutions according to Global Pharmaceutical Services (GPSI) spokesperson Keith Russell.

The deal combines ACR’s clinical research capacity with GPSI’s consultation, training and auditing services in a partnership that, they hope, will attract new customers in India and the US.

Russell told Outsoucing-pharma that part of the motivation for setting up the partnership was GPSI’s recognition of the need to build clinical R&D capacity that is attractive to potential sponsors.

Through its’ business activities with US pharma and biotech companies, GPSI had become apprised of the need for the placement of clinical studies in facilities that were conducting clinical studies efficiently and on time, at a reasonable cost and, most importantly, uncompromisingly meeting regulatory guidelines​.”

Dr. Emran Khan, Director of Abridge Clinical Research, was introduced to GPSI by a mutual business colleague. Following several information exchanges including in-depth discussions regarding business philosophies, opportunities for collaboration were identified​.”

Local knowledge

Russell explained that ACR will serve as project manager for all US trial sponsors, identifying the most appropriate service provider based on its knowledge of Indian contract research organizations (CRO).

He added that “Abridge Clinical Research will negotiate the contract directly with the service provider based upon a working proposal generated by the client or by Abridge Clinical Research.

“Contract negotiations will be done by an Abridge Clinical Research representative, in the local language who is knowledgeable of the business environment in India, which will mean a lower overall cost to the client.”

GPSI will act as US project manager for all studies conducted in India, providing clients with a point of contact that will, according to Russell, “eliminate the typical communication difficulties encountered when dealing on an international basis​.”

Related news

Show more

Related products

show more

How clinical trial software can optimize trials

How clinical trial software can optimize trials

Formedix | 09-Jun-2021 | Technical / White Paper

This article explains the different types of clinical trial software available, and how it can be used to optimize the end to end clinical trials design...

Adapting supply chains to new ways of working

Adapting supply chains to new ways of working

World Courier | 01-Jun-2021 | Technical / White Paper

COVID-19 has changed the way we operate. We have adapted our supply chain solutions to meet our clients’ requirements while following World Courier standard...

What are the building blocks of DCTs?

What are the building blocks of DCTs?

Medable | 26-Apr-2021 | Technical / White Paper

How to create a seamless experience across eConsent, eCOA and more.

Over the past year, tremendous progress was made toward digitizing and...

How a clinical metadata repository helps with data

How a clinical metadata repository helps with data

Formedix | 22-Mar-2021 | Technical / White Paper

This article covers the various ways a clinical metadata repository helps with data quality, and in turn, with data quality in the clinical trials process....

Related suppliers

Follow us


View more